Switching from Olanzapine to Quetiapine
Recommendations for Switching
- When switching from olanzapine 15 mg to quetiapine in an inpatient setting, a gradual cross-titration over 1-2 weeks is recommended to minimize discontinuation effects and maintain symptom control, as recommended by the Mayo Clinic Proceedings 1
- The inpatient setting provides an ideal environment for this switch, allowing for close monitoring of therapeutic response and potential side effects during the transition period, according to the Mayo Clinic Proceedings 1
Pharmacological Considerations
- Olanzapine has stronger dopamine D2, histamine H1, and muscarinic receptor binding compared to quetiapine, which may lead to different side effect profiles during transition, as noted by the Journal of the National Comprehensive Cancer Network 2
Management of Side Effects
- Both medications can cause sedation, with quetiapine often being more sedating initially, and consider administering the larger portion of the quetiapine dose at bedtime to manage sedation, as suggested by the Annals of Oncology 3
- Abrupt discontinuation of olanzapine can lead to withdrawal symptoms including nausea, vomiting, insomnia, and rebound psychosis, as warned by the Mayo Clinic Proceedings 1
Concomitant Medications
- Avoid combining olanzapine with other medications that cause dopamine blockade (like metoclopramide or haloperidol) during the transition to prevent extrapyramidal symptoms, as advised by the Journal of the National Comprehensive Cancer Network 2